Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy
Innovative Drug Access in Portugal: An Analysis of Managed Entry Agreements Supporting Public Coverage 2014-2024
Identifying bioaerosol diversity in theatmosphere of Vilnius, Lithuania, by molecular methods:Hints to clarify human bio-exposome.
Portuguese Global Medicines Access Index 2022: Intercalary Study
Assessing Pharmaceutical Innovation in Europe: Therapeutic Advances vs. Unmet Public Health Need